Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Chengdu Kanghong Biotech Co., Ltd.

Clinical trials sponsored by Chengdu Kanghong Biotech Co., Ltd., explained in plain language.

Not yet recruiting 1

New drug KHN922 aims to shrink advanced tumors in early trial

Disease control Not yet recruiting

This study tests a new drug, KHN922, in 276 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants receive the drug intravenously and are monitored for side effects and …

Phase: PHASE1, PHASE2 • Sponsor: Chengdu Kanghong Biotech Co., Ltd. • Aim: Disease control

Last updated Apr 29, 2026 15:04 UTC